Location: Home
  • search
  • go
  • Relate News
  • 2/7/2024I-Mab to Divest China Operations and Become a US-Focused Biotech
  • 2/7/2024NHC: China Continues to Improve Access to Public Medical Services
  • 2/7/2024Boao Lecheng Pilot Zone Experiments Expedited Entry into China's Healt...
  • 2/7/2024China's Basic Medical Insurance System Reports Revenue of CNY 2.7T in ...
  • 2/7/2024Review of Chinese Anti-tumor Hospital Drug Sales in 2023: Pharnexcloud
  • 2/7/2024Review and Outlook of China's Foreign Trade of Medicines and Health Pr...
  • 2/7/2024NMPA Restores Import, Sales and Use of GSK's BPH Drug
  • 2/7/2024CDE Issues the List of Reference Formulations for GQCE Studies (77th B...
  • 2/7/2024CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...
  • 2/7/2024CDE Issues the Dossier References for Drug R&D and Technical Evaluatio...
  • 2/7/2024CDE Issues the Technical Guidelines for Pharmaceutical Research on Mic...
  • 2/6/2024CDE Issues the Guidelines for Management and Review of Compliance Info...
  • 2/6/2024NMPA and Chinese Customs Announce Addition of Hefei Airport as a Drug ...
  • 2/6/2024CPC Expels Former Healthare Reform Official
  • 2/6/2024Potential Impact of the US Bill on Wuxi AppTec and Its Western Drugmak...
  • 2/6/2024 Luye Pharma Collaborates with Myung In Pharm in Advancing Treatment f...
  • 2/6/2024China Nearly Doubles Class 1 New Drugs in 2023
  • 2/6/2024Global Pharma Invests in China on the Strength of a Booming National B...
  • 2/6/2024Profit-flush China Pharma Firms Cast Eyes South (The Asset)
  • 2/5/2024Number of Pharmacists in China in 2022, by Region (Statista)
  • 2/5/2024Biotech Is the New Focus in U.S.-China Tech Rivalry (Axios)
  • 2/5/2024CDE Releases Its 2023 Drug Review Report
  • 2/5/2024CMS Licenses Greater China Rights of First-line Phosphate-lowering Dru...
  • 2/5/2024NHSA Issues the Centralizd Drug Procurement Platform Service Guideline...
  • 2/5/2024US Urges Indian Pharma to Distance from China for APIs amid Challenges...
  • 2/5/2024U.S. Congress Postpones Legislation Targeting Chinese Biotech Firms
  • 2/5/2024Eisai Encouraged by Market Potential of Its Alzheimer's Drug Leqembi i...
  • 2/4/2024CDE Issues the Technical Guidelines for Clinical Pharmacological Resea...
  • 2/4/2024CDE Issues the Technical Guidelines for Pharmaceutical Research of Rad...
  • 2/2/2024AmCham China's 26th Annual China Business Climate Survey: US Firms in ...
  • Page:75/776 Total number of articles:23255: [First][<<] [73] [74] [75] [76] [77] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group